Cancer immunotherapy
1 paper1 finding
- Funders: National Cancer Institute and 1 more
Upstream
1Thymus atrophy
downin humans1
1 study
Thymus atrophy
downin humans1
Thymus atrophy impairs cancer immunotherapy in humans.
Reviewcancer immunotherapy
Mechanism and intervention strategy of thymus atrophy in cancer immunotherapy
American journal of cancer research25 Aug 2026
Funding
3 grants since 2026National Cancer InstituteUS$1.3mEuropean Research Council€2m
P-Selectin-Targeting Nanoparticles to Potentiate Cancer Immunotherapy
National Cancer InstituteSloan-kettering Inst Can ResearchUS$709.1k2026–2030
Lifestyle as an Adjuvant to Cancer Immunotherapy
National Cancer InstituteUniversity of Pittsburgh at PittsburghUS$634.6k2026–2031
European Research CouncilFundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron€2m2026–2031